|
|
|
Volumn 44, Issue 7, 1993, Pages 640-644
|
|
Long-term high-dose neuroleptic treatment: Who gets it and why?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLORPROMAZINE;
FLUPHENAZINE;
HALOPERIDOL;
LOXAPINE;
NEUROLEPTIC AGENT;
TIOTIXENE;
ANGER;
ARTICLE;
CASE CONTROL STUDY;
CONTROLLED STUDY;
DELUSION;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
FEMALE;
HALLUCINATION;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PSYCHOSIS;
SCHIZOPHRENIA;
SEDATION;
SELF CARE;
VIOLENCE;
AFFECTIVE DISORDERS, PSYCHOTIC;
ANTIPSYCHOTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HALOPERIDOL;
HOSPITALS, PSYCHIATRIC;
HOSPITALS, STATE;
HUMAN;
LENGTH OF STAY;
MALE;
PATIENT COMPLIANCE;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOTIC DISORDERS;
REGRESSION (PSYCHOLOGY);
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SUICIDE;
SUPPORT, U.S. GOV'T, P.H.S.;
TREATMENT OUTCOME;
VIOLENCE;
|
|
EID: 0027211782
PISSN: 00221597
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (47)
|
|
References (0)
|
